Workflow
医疗光学组件
icon
Search documents
永新光学(603297):25H1业绩稳健增长,高端显微镜市场份额持续提升
Great Wall Securities· 2025-09-05 05:33
Investment Rating - The investment rating for the company is "Buy" [3][7]. Core Views - The company has achieved steady revenue growth in the high-end microscope market, with a market share exceeding 5% in domestic replacement [2]. - The company is focusing on four major business areas to drive performance, including high-end microscopes, barcode scanning, machine vision, and laser radar [2]. - The company has made significant progress in R&D and digital transformation, enhancing its technological capabilities in the optical field [2]. Financial Performance Summary - For the first half of 2025, the company reported revenue of 441 million yuan, a year-on-year increase of 2.95%, and a net profit attributable to shareholders of 108 million yuan, up 8.75% year-on-year [2]. - The gross profit margin for the first half of 2025 was 40.33%, an increase of 1.4 percentage points year-on-year, while the net profit margin was 24.55%, also up by 1.4 percentage points year-on-year [2]. - The company expects a recovery in the high-end microscope business in the second half of 2025, with a further increase in the high-end product proportion [2]. Financial Forecast - The company forecasts net profits attributable to shareholders of 271 million yuan, 351 million yuan, and 457 million yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 40, 31, and 24 times [7].